Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Patent coverage for Genta's BCL2-targeted antisense compounds

Nov. 15, 1996

Cell Therapeutics signs development and licensing agreements for lisofylline

Nov. 15, 1996

Auragen receives breast cancer research grant

Nov. 15, 1996

Potent new antitumor agents revealed by Takeda

Nov. 15, 1996

IND filed in Canada for Neovastat

Nov. 15, 1996

Eisai discloses antitumor compounds

Nov. 15, 1996

Antineoplastic tyrosine kinase inhibitors disclosed by Thomae

Nov. 15, 1996

Promising clinical trial results on Taxotere presented at ESMO meeting

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

First alternative to 5-FU controls disease progression in colorectal cancer

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...